| Literature DB >> 30258711 |
Jonathan I Watkinson1, Peter A Bowerman1,2, Kevin C Crosby1,3, Sherry B Hildreth1,4, Richard F Helm4, Brenda S J Winkel1.
Abstract
Plant flavonoid metabolism has served as a platform for understanding a range of fundamental biological phenomena, including providing some of the early insights into the subcellular organization of metabolism. Evidence assembled over the past three decades points to the organization of the component enzymes as a membrane-associated complex centered on the entry-point enzyme, chalcone synthase (CHS), with flux into branch pathways controlled by competitive protein interactions. Flavonoid enzymes have also been found in the nucleus in a variety of plant species, raising the possibility of alternative, or moonlighting functions for these proteins in this compartment. Here, we present evidence that CHS interacts with MOS9, a nuclear-localized protein that has been linked to epigenetic control of R genes that mediate effector-triggered immunity. Overexpression of MOS9 results in a reduction of CHS transcript levels and a metabolite profile that substantially intersects with the effects of a null mutation in CHS. These results suggest that the MOS9-CHS interaction may point to a previously-unknown mechanism for controlling the expression of the highly dynamic flavonoid pathway.Entities:
Keywords: Biotic and abiotic stress; Chalcone synthase; Flavonoid metabolism; MOS9; Nuclear localization; Protein interaction networks
Year: 2018 PMID: 30258711 PMCID: PMC6151112 DOI: 10.7717/peerj.5598
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 2.984
Figure 1Confirmation of the interaction of CHS with the At1g12530 protein.
(A) SPR analysis. Purified, recombinant CHS was immobilized on an SPR chip and purified, recombinant MOS9 passed over at the indicated concentrations. Each binding plot is shown as microresponse units (mRIU) over time and represents an average of three separate injections of MOS9. (B) FLIM-FRET analysis of At1g12530-SCFP3A and CHS-SYFP2 in Arabidopsis mesophyll protoplasts. N-terminal fusion constructs of either At1g12530 or CHS with cyan fluorescent protein and yellow fluorescent protein (respectively) were generated and used to transform living protoplasts. Fluorescence lifetime of At1g12530-SCFP3A alone was compared with its fluorescent lifetime in the presence of CHS-YFP2. Protoplasts are pseudo-colored to represent measured τ values. E-values for phase-shifts were calculated using n > 20 protoplasts (Table 1).
FLIM-FRET parameters for analysis of the CHS-MOS9 interaction in Arabidopsis protoplasts.
| Donor | Acceptor | τ(φ) ns ± S.D | τ( | ||
|---|---|---|---|---|---|
| MOS9-scfp3a | – | 24 | 2.36 ± 0.07 | 3.27 ± 0.05 | – |
| MOS9-scfp3a | CHS-syfp2 | 25 | 2.21 ± 0.08 | 3.24 ± 0.08 | 6.5% |
| MOS9-scfp3a | syfp2-CHS | 21 | 2.29 ± 0.13 | 3.37 ± 0.07 | 2.8% |
| MOS9-scfp3a | – | 12 | 2.40 ± 0.05 | 3.26 ± 0.03 | – |
| MOS9-scfp3a | syfp2 | 11 | 2.41 ± 0.03 | 3.17 ± 0.05 | 0.5% |
Note:
Results above and below the solid line are from independent experiments.
Figure 2Localization of MOS9 in wild-type and CHS-deficient roots.
MOS9-YFP fusion proteins were expressed from the de35S promoter in stably-transformed wild-type Col-0 (A) and tt4-11 plants (B). The root elongation zones of 5-day-old transgenic and Col-0 control (C) seedlings were examined by confocal laser scanning microscopy. All three images were taken under identical conditions and represent individual optical slices from stacks taken in the z-direction.
Figure 3Analysis of MOS9 (A) and CHS (B) expression in roots of 5-day-old MOS9 overexpression lines.
Transcript levels were analyzed by real-time PCR and normalized to the endogenous control gene, GAPDH. Error bars represent the standard error of the mean. Asterisks indicate a p-value < 0.02 from a two-tailed paired student’s t-test for expression of CHS relative to wild type. WT = wild type (Col-0).
Figure 4Metabolite profiling of de35S::MOS9::YFP, mos9-2, tt4-11, and Col seedlings.
(A) Principal component analysis (PCA) of UPLC-MS profiles for four biological replicates of each genetic background. (B) S-plot distribution of features between de35S::MOS9::YFP and Col-0 seedlings. Features shown in red were found to be associated with the MOS9 ectopic expression and were selected for further analysis.
Metabolites with altered levels in de35S::MOS9::YFP, mos9-2, and tt4-11 seedlings relative to wild-type Col-0.
| Putative identity | Retention time | Observed mass (adduct) | Ratio of change ( | ||
|---|---|---|---|---|---|
| I. Phenylalanine derivatives | |||||
| Sinapoyl-glutamate | 4.52 | 352.1027 ([M-H]−) | 1.1 (0.43) | ||
| 5.62 | 556.2656 ([M-H]−) | 1.1 (0.53) | 1.1 (0.33) | ||
| 1,2-Di- | 6.40 | 591.1711 ([M-H]−) | 1.1 (0.02) | 1.2 (0.29) | |
| 4-Benzoyloxybutyl-glucosinolate | 5.77 | 494.0788 ([M-H]−) | |||
| Quercetin-Rhamnose | |||||
| Monomer | 5.92 | 447.0922 ([M-H]−) | |||
| Biflavonoid | 5.23 | 446.0843 ([M-2H]2−) | |||
| Triflavonoid | 3.77 | 669.1270 ([M-2H]2−) | |||
| Syringaresinol glucoside | 6.00 | 579.2068 ([M-H]−) | |||
| II. Jasmonic acid precursors/Oxylipins | |||||
| Arabidopside A (isomer a) | 11.36 | 819.4523 ([M-H + HCO2H]−) | 1.2 (0.35) | −1.1 (0.25) | |
| Arabidopside A (isomer b) | 11.70 | 819.4523 ([M-H + HCO2H]−) | 1.3 (0.09) | −1.1 (0.32) | |
| Arabidopside C | 10.74 | 981.5046 ([M-H + HCO2H]−) | 1.3 (0.33) | ||
| III. As-yet unidentified | |||||
| UK Glycerolipid 1 | 9.91 | 855.4731 ([M-H + HCO2H]−) | 1.4 (0.07) | −1.0 (0.85) | |
| UK Glycerolipid 2 | 10.16 | 855.4741 ([M-H + HCO2H]−) | −1.1 (0.66) | ||
| UK Glycerolipid 3 | 10.22 | 957.4696 ([M-H + HCO2H]−) | 1.2 (0.22) | −1.2 (0.12) | |
| UK Glycerolipid 4 | 10.38 | 767.3841 ([M-H + HCO2H]−) | 1.0 (0.72) | −1.2 (0.10) | |
| UK sulfur-containing | 4.35 | 307.0847 ([M-H]−) | |||
| UK6 | 5.61 | 595.2021 ([M-H]−) | |||
| UK7 | 10.41 | 783.3788 ([M-H + HCO2H]−) | 1.1 (0.89) | ||
Notes:
UK, unknown; additional information on metabolite identification is presented in Table S1.
Statistically-significant values are highlighted in bold type.
n.d., not detected.